Trial Profile
A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2023
Price :
$35
*
At a glance
- Drugs Vilanterol (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 12 Sep 2023 Results from (HZA102942,HZA112776 and HZA112777) and two Phase 2b(HZA106855 and HZA106853) assessing compare model-predicted steady-state maximumplasma concentrations (Cmax) and overall systemicexposure (AUC0-24) of FF and VI in pediatric Japaneseand non-Japanese population subgroups presented at the 2023 American College of Clinical Pharmacology Annual Meeting
- 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.